project id: TCGA-READ; case submitter id: TCGA-AG-3599; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.7; rna integrity number: 9.4; age at index: 70; days to birth: -25749; ethnicity: not reported; gender: male; race: not reported; vital status: Alive; year of birth: 1937; age at diagnosis: 25749; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage I; ajcc pathologic t: T2; ajcc staging system edition: 5th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 366.0; icd 10 code: C19; last known disease status: not reported; morphology: 8480/3; primary diagnosis: Mucinous adenocarcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Rectosigmoid junction; synchronous malignancy: No; tissue or organ of origin: Rectosigmoid junction; tumor grade: Not Reported; year of diagnosis: 2007; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.7; longest dimension: 1.0; oct embedded: No; shortest dimension: 0.3; portion submitter id: TCGA-AG-3599-01A-02; percent necrosis: 0.0; percent normal cells: 15.0; percent stromal cells: 5.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0;